DNV supports the manufacturer’s transition to new regulation with its digital certification platform and transparent, predictable project management.

OSLO, Norway, March 31, 2026 /PRNewswire/ — DNV, a designated Notified Body for the European Union’s In Vitro Diagnostic Regulation (IVDR) and Medical Device Regulation (MDR), has been selected by a leading U.S. diagnostics manufacturer to certify near-patient diagnostic devices under the IVDR.

The engagement covers several families of Class D diagnostic devices, the highest-risk category under the IVDR. These include tests used to detect life-threatening diseases with a high risk of propagation requiring the most stringent regulatory oversight before entering the European market.

As manufacturers transition legacy devices to the IVDR, securing notified body capacity has become a critical step in maintaining access to the European market.

The IVDR, introduced in 2017 to replace the In Vitro Diagnostic Directive 98/79/EC (IVDD), significantly strengthens regulatory requirements for diagnostic devices in Europe, including stricter clinical evidence requirements and expanded involvement of notified bodies.

DNV was designated as a Notified Body under the IVDR in May 2025. With decades of experience in medical device certification, DNV supports manufacturers worldwide in navigating complex regulatory requirements and maintaining access to international markets.

The manufacturer already has an established working relationship with DNV, having previously certified several devices under other regulatory frameworks, including the multi-national Medical Device Single Audit Program (MDSAP).

The IVDR certification activities are being conducted through DNV’s digital certification platform, which allows manufacturers to upload and manage technical and performance documentation within a secure environment. The platform also facilitates efficient collaboration during the review process, helping streamline workflows and improve transparency.

“Having worked extensively with DNV on other certification schemes, we were confident in their expertise and collaborative approach. Their flexible project management and willingness to tailor certification timelines made them a natural partner for our IVDR certification. Their support on post-certification processes is also helping smooth our transition to the new regulation,” said a representative of the manufacturer.

“We are proud to support this manufacturer in achieving IVDR certification and maintaining access to the European market,” said Cecilie Gudesen Torp, VP and Managing Director, Medical Technologies at DNV. “Our goal is to make the certification process as efficient and transparent as possible by combining collaborative project management with digital tools that simplify documentation management and communication.”

-END-

Learn more at https://www.dnv.com/medical-devices/  

Sustainability and Corporate Responsibility Recognised by Global Capital Markets

HONG KONG, March 31, 2026 /PRNewswire/ — NetDragon Websoft Holdings Limited (“NetDragon” or “the Company”; Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce a notable upgrade in its Environmental, Social, and Governance (ESG) rating from BBB to A by the globally renowned index institution, MSCI. This upgrade reflects strong recognition from global capital markets of NetDragon’s overall performance in ESG areas, and further underscores the Company’s long-term investment value among international investors.

MSCI is a globally renowned provider of ESG rating for assessing companies’ performance in environmental, social and corporate governance. Its assessments are widely used by international institutional investors in investment decisions, asset allocation and risk management. As one of the earliest and most influential ESG rating providers, MSCI ESG Ratings are known for their independence, consistency and transparency, and currently cover more than 17,000 listed companies worldwide. As global capital markets continue to place increasing emphasis on sustainability and corporate governance, ESG ratings have become a key metric for evaluating a company’s long-term value and investment appeal. MSCI also offers a range of ESG-related indices based on its ratings, which are used as benchmarks by major global asset managers such as BlackRock, Vanguard and State Street for index-tracked ETF products.

The upgrade of NetDragon’s ESG rating to “A” reflects the Company’s ongoing efforts in integrating sustainability into its operations in recent years, with solid progress achieved across multiple areas including corporate governance, talent development, compliance management and social responsibility. This achievement is expected to further enhance the Company’s recognition and attractiveness in international capital markets, creating more favorable conditions for expanding its global investor base and supporting long-term value creation.

NetDragon has long been committed to fulfilling its corporate social responsibilities and promoting the deep integration of “AI + Education”  and “Gaming + Philanthropy,”  with the goal of delivering both commercial and social value. In education, the Company has actively participated in national-level digital education projects, supported the rollout of smart education and AI-powered learning systems, and advanced educational equity and access to quality resources across China and in multiple overseas markets. In the area of social impact, NetDragon continues to carry out a wide range of charitable initiatives, including support for rural education development and teacher training. Meanwhile, by leveraging its business strengths, NetDragon has integrated its gaming products with public welfare initiatives such as cultural heritage preservation and ecological protection, enhancing public engagement and broadening social impact while promoting the integration of digital content and social responsibility.

Looking ahead, NetDragon will continue to deepen its ESG practices by embedding sustainable development principles throughout its strategic planning and day-to-day operations. The Company will further strengthen its overall competitiveness, enhance its social responsibility efforts, leverage its industry strengths in education, gaming and digital innovation, and continue to improve its ESG performance, with the aim of creating long-term, stable and sustainable value for shareholders and all stakeholders.

About NetDragon Websoft Holdings Limited

NetDragon Websoft Holdings Limited (HKSE: 777) is a global leader in building internet communities, with a long track record of developing and scaling multiple internet and mobile platforms that impact hundreds of millions of users. Over the desktop and mobile internet eras, NetDragon previously established China’s first online gaming portal, 17173.com, and China’s most influential smartphone app store platform, 91 Wireless.  

Established in 1999, NetDragon is one of the most reputable and well-known online game developers in China with a history of successful game titles including Eudemons Online, Conquer Online, Heroes Evolved and Under Oath. In the past 10 years, NetDragon has also achieved success with its EdTech business both domestically and globally. Fully embracing the new AI era, NetDragon is driving its vision of “Infinite Growth” through a dual-focus strategy of “AI+Gaming” and “AI+Education”. With its AI Content Factory empowering operations and working with partners to develop a global learning metaverse, NetDragon is committed to once again building a massive user community in the new AI era.

NetDragon’s overseas edtech business entity, currently a U.S.-listed subsidiary named Mynd.ai, is a global leader in interactive technology and its award-winning interactive displays and software can be found in more than 2 million learning and training spaces across 126 countries.  

For investor enquiries, please contact:

NetDragon Websoft Holdings Limited
Email： ir@netdragon.com

SHANGHAI, March 31, 2026 /PRNewswire/ — On 30 March, 2026, Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter, HKEX code: 02256.HK) announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug (IND) application for ABSK061, a highly selective small-molecule FGFR2/3 inhibitor, for the treatment of children with achondroplasia (ACH). Coupled with the recent Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) granted by the FDA, this will help Abbisko accelerate the overseas clinical development process for ABSK061.

ABSK061 is currently being evaluated in a Phase II clinical trial for ACH, and in December 2025, the study dosed its first patient in China. Preliminary data are expected to be reported in the second half of 2026. As an important part in the global development strategy for ABSK061, Abbisko plans to enroll US patients into the Phase II study to further evaluate safety, tolerability, and efficacy of ABSK061 for the treatment of ACH.

Achondroplasia is a rare autosomal genetic disorder that causes severe growth and developmental impairments. Research has shown that the pathogenesis of ACH is driven by aberrant activation of the fibroblast Growth Factor Receptor 3 (FGFR3) caused by FGFR3 gene mutations, which suppress normal endochondral ossification ^[1]. Targeted inhibitors offer the potential to deliver more precise and effective treatment options for ACH patients.

ABSK061, independently developed by Abbisko Therapeutics, is a highly potent and selective small-molecule FGFR2/3 inhibitor. It has demonstrated robust target inhibitory activity, favorable pharmacokinetic properties, and a promising safety profile in preclinical studies. Its oral administration offers significant advantages in terms of convenience and treatment compliance-particularly for pediatric patients—and positions ABSK061 as a potentially valuable therapeutic candidate for children and adolescents with ACH.

About ABSK061

ABSK061 is a novel, orally bioavailable, highly potent and selective small molecule inhibitor of FGFR2 and FGFR3 independently discovered and wholly-owned by Abbisko Therapeutics. It is the first FGFR2/3 inhibitor to enter clinical trials globally. First-generation pan-FGFR inhibitors demonstrated clinical efficacy in multiple tumors carrying FGFR2/3 variants and have steadily gained regulatory approval globally. However, the therapeutic window of pan-FGFRs and their clinical efficacy have been limited by side effects associated with FGFR1 inhibition. By reducing FGFR1 activity while maintaining potency against FGFR2 and FGFR3, ABSK061 is expected to achieve a wider therapeutic window with improved clinical efficacy as a new-generation of FGFR inhibitors. ABSK061 for the treatment of achondroplasia has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA), and its Phase II clinical trial is currently ongoing.

MUMBAI, India, March 31, 2026 /PRNewswire/ — Tata Communications today redefined resilience for the global digital economy with the launch of IZO™ Data Centre* Dynamic Connectivity, a software-defined platform designed to transform how enterprises connect their Data Centres in an increasing AI driven and distributed world. 

In today’s digital economy, every enterprise depends on the ability to always be connected with an uninterrupted data flow. From financial transactions, IT-ITeS, Manufacturing etc. to streaming platforms and online retail, the connections between data centres keep the modern world running. When those connections are interrupted, businesses do not just slow down, they bring them to a complete standstill.

Yet the networks connecting many enterprise data centres were built for a different era. Traditional DC-to-DC links were designed for predictable workloads and stable traffic patterns. Today’s reality is far more dynamic. Enterprises operate across global locations and cloud environments, moving massive volumes of data in real time to support AI workloads and business needs.

In an environment shaped by increasing geopolitical constraints, cable outages, route failures, or sudden spikes in demand, these can quickly cascade into service disruption and operational risk, leading to a costly downtime. In such scenarios, the response is often reactive and manual, consuming valuable time when business need certainty and speed.  

Tata Communications’ IZO™ DC Dynamic Connectivity addresses this challenge by introducing a self-healing, intelligent network that covers key global data centers across 5 continents. Unlike conventional architectures, this platform uses deterministic multi-path routing to deliver predictable latency and performance. This means the platform  is smart enough to automatically re-route traffic within seconds – without manual intervention during disruptions. This enables enterprises to achieve >99.99% service availability across mission-critical infrastructure that supports business-critical applications, turning resilience from a contingency into a default state.

The platform also gives enterprises access over their connectivity. Through a unified digital interface and APIs, enterprises can monitor performance, receive proactive alerts, and dynamically scale bandwidth as workloads evolve. Business leaders no longer have to guess their future needs or over-pay for ‘just in case’ bandwidth. The system provides Al-driven predictive insights allowing companies to forecast their capacity requirements in advance. If a sudden workload demands more capacity or choice of route, users can instantly scale their bandwidth or add route through self-service feature.

The business impact is a shift from crisis management to strategic growth. By moving to a flexible, consumption-based pricing model, enterprises can reduce the need for idle backup capacity and save up to 30% on operational costs. Enterprises can activate resilience and bandwidth only when required, helping optimise costs while maintaining deterministic performance across geographies.

This is the Tata Communications advantage: combining enterprise-grade agility with predictive intelligence to keep the world’s most important data moving and ensuring enterprises are always on and always connected.

Commenting on the launch, Genius Wong, Executive Vice President, Core and Next-Gen Connectivity Services and Chief Technology Officer, Tata Communications, said: “Data centres are the core engines of today’s digital economy, and the connections between them must be as resilient as the networks that connect them. They must be just as dynamic as the applications they support. With IZO™ DC Dynamic Connectivity, we are shifting resilience from a reactive process to an autonomous capability. By combining global reach, deterministic routing and intelligent automation, we are enabling enterprises to build a digital foundation that scales with confidence and operates without disruption.”

About Tata Communications

A part of the Tata Group, Tata Communications (NSE: TATACOMM) (BSE: 500483) is a global digital ecosystem enabler powering today’s fast-growing digital economy in more than 190 countries and territories. Leading with trust, it enables digital transformation of enterprises globally with collaboration and connected solutions, core and next gen connectivity, cloud hosting and security solutions and media services. 300 of the Fortune 500 companies are its customers and the company connects businesses to 80% of the world’s cloud giants. For more information, please visit www.tatacommunications.com       

Forward-looking and cautionary statements

Certain words and statements in this release concerning Tata Communications and its prospects, and other statements, including those relating to Tata Communications’ expected financial position, business strategy, the future development of Tata Communications’ operations, and the general economy in India, are forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors, including financial, regulatory and environmental, as well as those relating to industry growth and trend projections, which may cause actual results, performance or achievements of Tata Communications, or industry results, to differ materially from those expressed or implied by such forward-looking statements. The important factors that could cause actual results, performance or achievements to differ materially from such forward-looking statements include, among others, failure to increase the volume of traffic on Tata Communications’ network; failure to develop new products and services that meet customer demands and generate acceptable margins; failure to successfully complete commercial testing of new technology and information systems to support new products and services, including voice transmission services; failure to stabilize or reduce the rate of price compression on certain of the company’s communications services; failure to integrate strategic acquisitions and changes in government policies or regulations of India and, in particular, changes relating to the administration of Tata Communications’ industry; and, in general, the economic, business and credit conditions in India. Additional factors that could cause actual results, performance or achievements to differ materially from such forward-looking statements, many of which are not in Tata Communications’ control, include, but are not limited to, those risk factors discussed in Tata Communications Limited’s Annual Reports. 

The Annual Reports of Tata Communications Limited are available at www.tatacommunications.com. Tata Communications is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements.

^© 2026 Tata Communications Ltd. All rights reserved. TATA COMMUNICATIONS and TATA are trademarks or registered trademarks of Tata Sons Private Limited in India and certain countries. All other third-party trademarks belong to their respective owners.

*DC Stand for Data Centre